CTX Life Sciences Private LimitedView mapNavi Mumbai, Maharashtra
Products and Services
- API - Commercial
- Metoprolol Succinate
- Xylometazoline Hydrochloride
- Hydrated Dihydralazine Sulfate
- Olmesartan Medoxomil
- Sevelamer Hydrochloride
CTX Lifesciences is an Active Pharmaceutical Ingredient (API) and intermediate manufacturing company, having a cGMP facility spread over 38 acres of land located at Sachin, in the district of Surat, Gujarat, India.
About UsCTX Life Sciences strongly believes that with its excellent infrastructure and extensive chemical business background, it is aptly positioned for APIs & Intermediates manufacturing and outsourcing for global pharmaceutical & chemical industries.
The ultimate business strategy of CTX Life Sciences is “ to be a partner in the global pharmaceutical and chemical industries and continue to be a reliable and consistent supplier of APIs and Intermediates ”.
APIs and Intermediates
CTX Life Sciences inherits the ‘chemistry’ & 'enviroment infrastructure' strength from its parent company to become a global supplier of APIs and Intermediates to pharmaceutical and chemical industries, by utilizing its ability to handle complex chemical synthesis. The company has built up strength in the development, process optimization, scale-up and cGMP production of APIs and Intermediates.
The company carefully analyses & evaluates Intellectual Property Rights (IPR) to avoid patent infringement.
CTX Life Sciences capabilities include non-infringing synthetic route selection with respect to patents, processes and analytical validation, optimization and successful scale-up from bench to manufacturing. Production is undertaken in the state-of-the-art multi-purpose cGMP compliant manufacturing facility. In order to meet the regulatory requirements, molecule formation, isolation of API and their subsequent operations such as drying, milling, blending and packing are carried out in a facility having cGMP practices.
CTX Life Sciences has a large intermediate plant capable of handling complex reactions and has the capability of manufacturing as per customer requirements.
Board of DirectorsMr. Jayanthibhai Jariwala, Chairman
Mr. Pravin Kabutarwala
Mr. Kanak Jariwala
Jayantibhai Jariwala Chariman
Our ManagementKey Personnel
|Mr. Kanak Jariwala||:||Director|
|Mr. P.P.S. Kishore||:||Vice President - Operations|
|Dr. P.Y. Kolhe||:||Vice President - R & D|
|Mr. Amit Mondal||:||Vice President - Q.A. & Regulatory Affairs|
Board of Directors :
|Mr. Jayanthibhai Jariwala, Chairman|
|Mr. Pravin Kabutarwala|
|Mr. Kanak Jariwala|
Our Vision“ To be the preferred strategic partner for the pharmaceutical industry and share responsibilities for the enhancement of human health.”
Our Mission“ To develop and manufacture Active Pharmaceutical Ingredients (APIs) and Intermediates for global supply, complying with quality and regulatory requirements of our customers.”
- World class performance
- Respect for Environment
- Cohesive team-work
- Innovative culture
- Noninfringing process
- Quality Consciousness
- Collaborative approach with Customers
Our Group of CompaniesMr. Jayantibhai Jariwala, Chairman and Managing Director of Colourtex Group of companies, founded the parent company in the late sixties. Colourtex has since grown strongly over the last four decades into a leading dyestuff producer, having a fully integrated state-of-the-art plant with annual installed capacity of 57,000 MTA dyes, 68,000 MTA dye-intermediates and 8,000 MTA Speciality Chemicals.
Colourtex has emerged globally as a leading Indian dyestuff company with an annual sale exceeding $250 million.
In the past decade, major investments have been done into building environment and resource infrastructure, including 7MW power generation, 60,000 m3 surface water reservoir with water treatment plant, liquid and solid disposal facility along with incinerators. The facilities are accredited by ISO 9001-2008, ISO - 14001-2004, ISO 18001-2007, ETAD Member.
Awards & Recognition
- R & D approved by CSIR, Department of Science & Technology, Govt. of India
- Best Paper published in the discipline of Pharmaceutical Analysisin the year 2010 & 2011
Corporate Social ResponsibilitiesCTX is proud to be a responsible corporate citizen and pledged a degree of responsibility for the cause of society.
Our Corporate Social Responsibility reflects our interdependent association with the society. This ethos involves initiatives on a micro level to include employee and public safety, nurturing of environment and building sustainable communities and makes us revisit our facilities, standards, work practices and requirements from a wider perspective.
Our activities for the cause of society have emerged in response to both the needs as expressed by the community and an assessment of the situation by our management.
- Great HR environment and team to work and grow with
- Proven competence in chemistry
- Well directed R&D facilities
- cGMP compliant, US FDA inspected & Compliant, EU GMP Certified, PMDA JAPAN Accreditation
- Proven abilities to scale from bench to mass manufacturing
- Adherence to strictest quality parameters
- Unitary focus on emerging as the supplier of choice for world class API’s and intermediates
- Capacity to manufacture complex reaction based intermediates
- Enlightened promoters who work on trust and belief in the team
Research & DevelopmentR & D approved by CSIR, Department of Science & Technology, Govt. of India
We have Highly qualified and experienced scientific team and independent laboratories for chemical synthesis development and analytical method development and validations.
Creating a product pipeline through Research and Development
The company consistently developes non patent infringing processes to expand its pipeline of products. We have begun our manufacturing journey with generic products but our labs and R&D team is actively seeking to come up with processes that will enable us to manufacture and market generic versions of products that are scheduled to go off patent.
Warehouse FacilitiesWarehouse covers an area of 38,000 sq.ft. for handling of all incoming raw materials, packing materials and finished products with pre-defined storage conditions. Facilities for handling of gases, hazardous chemicals and solvents independently.
- European Commission
- Ministry of Health and Medical Education (Iran)
Quality Policy“We strive to achieve the highest standards of quality by inculcating quality culture throughout the organization and commit ourselves to the highest standards in our products and services by conforming to the cGMP standards and continuously improving all that we do for our internal and external customers”.
Production FacilityCTX Life Sciences Pvt. Ltd. has capability to operate the following chemical reactions.
- Addition reaction
- Beckmann Rearrangement
- Chiral separation/ resolution
- Coupling reaction
- Friedel Craft acylation
- Grignard reaction
- Mannich Reaction
- Michael Addition
- Nucleophilic substitution
- Perkin reaction
Quality AssuranceQ.A. and Regulatory Affairs team comprises of a wealth of experience in all areas of cGMP implementation, audits and compliance, Regulatory Dossier preparation, submission, deficiency response, updation to regulatory agencies and customers.
Quality StandardsState-Of-the-Art quality control laboratories spread over an area of 13,000 sq.ft with Chemical, Instrumental, Particle Size distribution and Microbiology analysis facilities. Stability chamber for all ICH recommended condition and control sample management facilties.
- Nature of Business
Navi Mumbai - 400614